operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-08Mar2022 Final

Page 66

Pfizer Operational phase • Use a daily checklist to monitor and ensure IPC and other safety measures are • • •

• •

adhered to. Consider a daily ‘huddle’ to enhance teamwork and to highlight any IPC issues. Screen all staff for signs and symptoms of COVID-19 at the start of each shift. Screen all people arriving for vaccination for COVID signs and symptoms, especially those people who meet the New Zealand/Aotearoa Government ‘higher index of suspicion’ (HIS) criteria. For additional screening questions see Appendix G. Ensure the scheduling of vaccination appointments avoids over-crowding and allows for physical distancing and other IPC measures. Also, limit the number of accompanying people to only those who need assistance, whether physical or psychosocial. Ensure the appropriate processes are in place to prevent under-age vaccinations – this is a never event. Ensure the appropriate processes are in place to prevent second dose vaccinations earlier than 21 days – this is a never event.

Note: In the rare occurrence where an authorised prescriber deems the vaccine clinically indicated for a consumer, the authorised prescriber can prescribe the vaccine as off label/ unapproved use. This must be documented clearly including the rationale for early second dose and the informed consent process. A CARM report does not need to be completed if the vaccine has been prescribed by an authorised prescriber. Written consent is advised.

Key IPC measures to implement Prepare each injection in a clean, designated area. Hand hygiene • At the start of the shift, all vaccination team members are required to wash their hands

thoroughly with soap and water and dry them thoroughly or use hand sanitiser. • Facilitate attending consumers’ hand hygiene (as above). • Vaccinators should perform hand hygiene before putting on and removing PPE, before

preparing the vaccine, and between each vaccine administration, preferably using alcohol-based hand sanitisers. • Gloves are not required and, if used, do not replace the need for hand hygiene between each vaccine administration and for other indications. The use of alcohol hand sanitisers on gloves is strongly discouraged. PPE • PPE is to be selected based on risk assessment as a part of standard precautions. • In the context of the COVID-19 pandemic, vaccinators should wear PPE appropriate to

the public health risk and current COVID-19 Alert Level settings.

Version 34.0 Page 66


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

5min
pages 168-169

Appendix G: Vaccination site screening questions

2min
page 159

Appendix J: Risk mitigations for vaccination sites

2min
page 167

Appendix E: CVIP logistics overview/cheat sheets

4min
pages 156-157

Appendix D: Logistics and inventory management

1min
page 155

Incidents

6min
pages 137-141

Variations

1min
page 142

Affected persons under the Vaccinations Order

4min
pages 128-130

National Immunisation Booking System

11min
pages 131-136

Home vaccinations

2min
pages 125-126

Mobile vaccination team

1min
page 124

COVID-19 Trial Vaccinations

1min
page 127

Vaccination in Hospital

1min
page 123

Vaccination and Surveillance Testing

1min
page 122

Third primary dose for severely immunocompromised

1min
page 121

Section F: Additional programme guidance, variations and incidents

1min
page 117

Vaccination in high-risk or screened ‘positive’ consumers

5min
pages 118-120

Novavax Operational phase

1min
page 108

Novavax Vaccine administration and observation

8min
pages 111-116

Novavax Preparation of doses

2min
pages 109-110

Booking and scheduling

1min
page 107

Section E: Novavax (Nuvaxovid) COVID-19 Vaccine

1min
page 106

AstraZeneca Vaccine administration and observation

8min
pages 100-105

AstraZeneca Preparation of doses

2min
pages 98-99

AstraZeneca Operational phase

1min
page 97

Paediatric Pfizer Vaccine administration and observation

9min
pages 89-94

Section D: AstraZeneca COVID-19 Vaccine

1min
page 95

Booking and scheduling

1min
page 96

Paediatric Pfizer Preparation of doses

3min
pages 86-88

Vaccine safety and additional considerations for consumers aged 5 to 11 years

1min
page 85

Pfizer Vaccine administration and observation

13min
pages 72-81

Booking and scheduling

3min
pages 62-64

Vaccinating consumers aged 12 to 15 years

1min
page 68

Pfizer Preparation of doses

4min
pages 69-71

Pfizer Operational phase

2min
pages 66-67

Protecting security and privacy

1min
page 65

Becoming a COVID-19 Vaccination site

1min
page 60

Site readiness and closure

1min
page 59

Disposal of consumables, vaccine, and vaccine packaging

2min
pages 57-58

COVID-19 Immunisation Register

3min
pages 29-31

Preparing the vaccination workforce

7min
pages 22-26

Infection prevention and control (IPC

2min
pages 27-28

Section A: Ready to vaccinate

1min
page 15

Site considerations

7min
pages 18-21

Equipment ordering and demand planning

7min
pages 33-38

Vaccine storage and handling

8min
pages 39-44

Logistics

1min
page 32
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.